ARS Pharmaceuticals, Inc. Share Price

ARS Pharmaceuticals, Inc. Share Price

NASDAQ: SPRY | Small Cap
$3.82
+$0.17 (4.66%) Last updated on 29 Oct, 2026 | 19:53 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

ARS Pharmaceuticals, Inc. Stock Performance

Open
$3.74
Prev. Close
$3.65
Circuit Range
N/A
Day Range
$3.73 - $3.83
Year Range
$3.53 - $13.14
Volume
14,281
Average Traded
$3.78

ARS Pharmaceuticals, Inc. Share Price Today

As of 29 October 2026, ARS Pharmaceuticals, Inc.'s share price is $3.82. The stock opened at $3.74, compared to its previous close of $3.65. During today's trading session, ARS Pharmaceuticals, Inc.'s share price traded between $3.73 and $3.83, with an average price of $3.78. Over the past 52 weeks, the stock has recorded a high of $13.14 and a low of $3.53. In terms of performance, ARS Pharmaceuticals, Inc.'s share price has declined by 53.70% over the last six months and is down 57.27% on a year-on-year basis.

ARS Pharmaceuticals, Inc. Share Price Chart

Line chart of the ARS Pharmaceuticals, Inc. price trend over the selected period. The price rose overall, ranging from 3.73 to 3.83, ending at 3.82.
$3.73$3.83
L
Show Current Price
H

ARS Pharmaceuticals, Inc. Stock Fundamentals & Key Indicators

Market Cap
$376.52M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-2.16
Revenue (TTM)
$84.28B
Return On Equity (TTM)
-1719.68%
Profit Margin
-203.25%
Debt to Equity
13.72
Quarterly Earnings Growth YoY
-21.97%

ARS Pharmaceuticals, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$32.50$28.09$22.68$33.66
Net Profit-$51.11-$41.10-$60.62-$62.34
Net Profit Margin-157.26%-146.32%-267.28%-185.20%
Income ChangeN/A19.59%-47.49%-2.84%

ARS Pharmaceuticals, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$1.32$0.03$89.15$84.28
Net Profit-$34.68-$54.37$8.00-$171.30
Net Profit Margin-2627.27%-181233.33%8.97%-203.25%
Income ChangeN/A-56.78%114.71%-2241.25%

About ARS Pharmaceuticals, Inc.

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the commercialization and development of neffy (currently identified in the European Union (EU) and United Kingdom (U.K.) by the trade name EURneffy and in China) for needle-free intranasal delivery of epinephrine for emergency treatment of Type I allergic reactions, including anaphylaxis. Neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows Neffy to safely provide intranasal delivery of epinephrine at a low dose within the exposures of approved injectable products across a range of dosing conditions.

ARS Pharmaceuticals, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$4.36
$3.77
-13.05%
Sep 2026
$5.99
$4.33
-28.07%
Aug 2026
$5.02
$6.02
+17.81%
Jul 2026
$8.01
$5.11
-36.20%
Jun 2026
$9.25
$8.01
-11.69%
May 2026
$8.28
$9.07
+9.94%
Apr 2026
$8.18
$8.25
+2.75%
Mar 2026
$8.99
$8.03
-13.67%
Feb 2026
$10.00
$9.30
-7.09%
Jan 2026
$11.52
$10.01
-14.15%
Dec 2025
$9.37
$11.66
+22.35%
Nov 2025
$9.01
$9.53
+6.60%

SPRY Share Price FAQs